95 related articles for article (PubMed ID: 7940453)
1. [A Norwegian conference on updating of the treatment of Helicobacter pylori in peptic ulcer. Interessegruppe for Gastroenterologi].
Tidsskr Nor Laegeforen; 1994 Sep; 114(21):2495-7. PubMed ID: 7940453
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
3. Furazolidone, amoxicillin and omeprazole with or without bismuth for eradication of Helicobacter pylori in peptic ulcer disease.
Ghadir MR; Shafaghi A; Iranikhah A; Pakdin A; Joukar F; Mansour-Ghanaei F
Turk J Gastroenterol; 2011 Feb; 22(1):1-5. PubMed ID: 21480103
[TBL] [Abstract][Full Text] [Related]
4. [10 days of triple treatment of Helicobacter pylori infection and peptic ulcer. Status after treatment of 4 weeks and of one year].
Berstad A; Berstad K; Hatlebakk JG; Wilhelmsen I; Nysaeter G; Bang CJ; Hausken T; Nesje LB; Hjartholm AS; Hundal O
Tidsskr Nor Laegeforen; 1994 Sep; 114(21):2477-9. PubMed ID: 7940447
[TBL] [Abstract][Full Text] [Related]
5. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial.
Salmanroghani H; Mirvakili M; Baghbanian M; Salmanroghani R; Sanati G; Yazdian P
PLoS One; 2018; 13(6):e0197096. PubMed ID: 29889843
[TBL] [Abstract][Full Text] [Related]
7. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study.
Saberi-Firoozi M; Massarrat S; Zare S; Fattahi M; Javan A; Etaati H; Dehbashi N
Am J Gastroenterol; 1995 Sep; 90(9):1419-23. PubMed ID: 7661161
[TBL] [Abstract][Full Text] [Related]
8. Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
Labenz J; Stolte M; Peitz U; Tillenburg B; Köhl H; Becker T; Börsch G
Z Gastroenterol; 1995 Oct; 33(10):590-3. PubMed ID: 7502551
[TBL] [Abstract][Full Text] [Related]
9. Are twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating H. pylori infection in peptic ulcer and in non-ulcer dyspepsia?
Gisbert JP; Hermida C; Pajares JM
Hepatogastroenterology; 2001; 48(41):1383-8. PubMed ID: 11677970
[TBL] [Abstract][Full Text] [Related]
10. The role of acid inhibition in the treatment of Helicobacter pylori infection.
Axon AT
Scand J Gastroenterol Suppl; 1994; 201():16-23. PubMed ID: 8047818
[TBL] [Abstract][Full Text] [Related]
11. [Helicobacter pylori eradication: triple therapy versus dual therapy].
Dammann HG
Fortschr Med; 1996 Feb; 114(4):34-8. PubMed ID: 8852685
[TBL] [Abstract][Full Text] [Related]
12. Bismuth therapy for Helicobacter pylori infection. A review of five years experience at a university hospital in Norway.
Berstad A; Olafsson S; Tefera S; Berstad K; Hundal O; Bergseth M; Wilhelmsen I
J Physiol Pharmacol; 1996 Mar; 47(1):31-49. PubMed ID: 8777305
[TBL] [Abstract][Full Text] [Related]
13. Pylera plus omeprazole: quadruple treatment for Helicobacter pylori.
Baker DE
Rev Gastroenterol Disord; 2008; 8(1):33-41. PubMed ID: 18477968
[TBL] [Abstract][Full Text] [Related]
14. [Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
Domschke W; Dettmer A; Fenner T; Gregor M; Hesse P; Holtmann G; van Husen N; Miederer SE; Schentke KU; Schütz E
Z Gastroenterol; 1995 Oct; 33(10):598-601. PubMed ID: 7502553
[No Abstract] [Full Text] [Related]
15. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
Vakil N; Fennerty MB
Am J Gastroenterol; 1996 Feb; 91(2):239-45. PubMed ID: 8607487
[TBL] [Abstract][Full Text] [Related]
16. 90% cure: which anti-Helicobacter therapy can achieve this treatment goal?
de Boer WA; Tytgat GN
Am J Gastroenterol; 1995 Sep; 90(9):1381-2. PubMed ID: 7661154
[No Abstract] [Full Text] [Related]
17. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
18. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Avidan B; Melzer E; Keller N; Bar-Meir S
Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
[TBL] [Abstract][Full Text] [Related]
19. Triple therapy with sucralfate, tetracycline, and metronidazole for Helicobacter pylori-associated duodenal ulcers.
Sung JJ; Leung VK; Chung SC; Ling TK; Suen R; Cheng AF; Li AK
Am J Gastroenterol; 1995 Sep; 90(9):1424-7. PubMed ID: 7661162
[TBL] [Abstract][Full Text] [Related]
20. Treatment strategies for Helicobacter pylori infection.
Damianos AJ; McGarrity TJ
Am Fam Physician; 1997 Jun; 55(8):2765-74, 2784-6. PubMed ID: 9191460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
